Maravai Life Sciences – Falling Victim To COVID Boom & Bust (NASDAQ:MRVI)

Burst your bubble thumbtack and balloon background


Investment Overview – Maravai’s Monster IPO Amid COVID Vaccine Hype

Maravai LifeSciences (NASDAQ:MRVI) joined the Nasdaq back in November 2020, its Initial Public Offering (“IPO”) raising an astounding $1.62bn via the issuance of ~60m shares, priced at $27 per share.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *